Publications by authors named "Hanlon Sia"

Claim this Profile
B
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial.
Vania Hungria, Paweł Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, Hanlon Sia

Lancet Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.
Emma Verner, Amanda Johnston, Nalini Pati, Eliza A Hawkes, Hui-Peng Lee, Hanlon Sia

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.
Vania Hungria, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, Hanlon Sia

N Engl J Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma.
Thomas Martin, Joseph Mikhael, Roman Hajek, Kihyun Kim, Kenshi Suzuki, Hanlon Sia

Blood Adv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading.
Cameron J McDonald, Gautam Rishi, Eriza S Secondes, Lesa Ostini, Daniel F Wallace, Hanlon Sia

Hum Genomics· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus-negative Hodgkin lymphoma presenting as haemophagocytic lymphohistiocytosis.
Yasmin Harvey, Helen Wordsworth, Hanlon Sia

Br J Haematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis